Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|
Super Panel Plus NxGen MDx United States | 116 | 117 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Fragile X NxGen MDx United States | 1 | 1 | - T Targeted variant analysis
|
Custom JHP NxGen MDx United States | 8 | 7 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Universal Panel Plus NxGen MDx United States | 21 | 22 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Ashkenazi Jewish Panel NxGen MDx United States | 20 | 21 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Super Panel 113 NxGen MDx United States | 113 | 115 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Essential Panel NxGen MDx United States | 3 | 4 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
IMPORTANT NOTE: NIH does not independently verify information submitted to
the GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute
for medical advice. Patients and consumers with specific questions
about a genetic test should contact a health care provider or a genetics professional.